AddLife Dirección

Dirección controles de criterios 2/4

El CEO de AddLife's es Fredrik Dalborg , nombrado en Jan 2022, tiene una permanencia de 2.25 años. compensación anual total es SEK8.70M, compuesta por 56.8% salario y 43.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.02% de las acciones de la empresa, por valor de €220.76K. La antigüedad media del equipo directivo y de la junta directiva es de 0.7 años y 8.6 años, respectivamente.

Información clave

Fredrik Dalborg

Chief Executive Officer (CEO)

kr8.7m

Compensación total

Porcentaje del salario del CEO	56.8%
Permanencia del CEO	2.4yrs
Participación del CEO	0.03%
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	8.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Fredrik Dalborg en comparación con los beneficios de AddLife?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	kr78m
Dec 31 2023	kr9m	kr5m	kr190m
Sep 30 2023	n/a	n/a	kr293m
Jun 30 2023	n/a	n/a	kr388m
Mar 31 2023	n/a	n/a	kr429m
Dec 31 2022	kr6m	kr2m	kr480m

Compensación vs. Mercado: La compensación total de Fredrik($USD799.48K) está por debajo de la media de empresas de tamaño similar en el mercado German ($USD1.29M).

Compensación vs. Ingresos: La compensación de Fredrik ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.

CEO

Fredrik Dalborg (52 yo)

2.4yrs

Permanencia

kr8,704,000

Compensación

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Fredrik Dalborg	President & CEO	2.4yrs	kr8.70m	0.026% SEK 327.0k
Christina Rubenhag	Chief Financial Officer	2.4yrs	sin datos	0.0053% SEK 66.5k
Julie O'Leary	Investor Relations Manager	less than a year	sin datos	sin datos
Christian Karlsson	Head of Business Development	3.4yrs	sin datos	sin datos
Per Wahlstedt	Head of Business Control	2.4yrs	sin datos	sin datos
Timmy Rosendal	Head of Sustainability	less than a year	sin datos	sin datos
Ioana Dragan	Head of Financial Control	less than a year	sin datos	sin datos
Jamilah Wass	Group Financial Controller	no data	sin datos	sin datos
Nichlas Essner	Group Business Controller	less than a year	sin datos	sin datos
Malin Lindh	Group Business Controller	less than a year	sin datos	sin datos

0.8yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de 1AD1 no se considera experimentado ( 0.7 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Birgit Norinder	Independent Director	8.8yrs	kr350.00k	0.010% SEK 129.4k
Eva Elmstedt	Independent Director	3.1yrs	kr350.00k	0.0041% SEK 51.2k
Johan Sjo	Independent Chairman	9.3yrs	kr700.00k	0.14% SEK 1.7m
Håkan Roos	Independent Director	8.9yrs	kr350.00k	4.75% SEK 59.3m
Eva Nilsagard	Independent Director	8.5yrs	kr500.00k	0.0046% SEK 57.0k
Stefan Hedelius	Independent Director	8.8yrs	kr350.00k	0.024% SEK 302.3k

8.8yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de 1AD1 se considera experimentada (8.6 años de antigüedad promedio).

AddLife Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Insufficient new directors

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought €1.0m worth of stock

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Recent updates

Insufficient new directors

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

First quarter 2024 earnings released: EPS: kr0.51 (vs kr1.43 in 1Q 2023)

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

Independent Director recently bought €2.8m worth of stock

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

Dividend of kr0.50 announced

Full year 2023 earnings released: EPS: kr1.56 (vs kr3.94 in FY 2022)

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

Now 22% undervalued after recent price drop

AddLife AB (publ), Annual General Meeting, May 08, 2024

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 33%

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Investor sentiment deteriorates as stock falls 15%

Independent Director recently bought €1.0m worth of stock

Addlife AB (Publ) Declares Dividend

Investor sentiment improves as stock rises 22%

Upcoming dividend of kr1.20 per share at 1.0% yield

First quarter 2023 earnings released

President & CEO recently bought €12k worth of stock

President & CEO recently bought €10.0k worth of stock

Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021)

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

Third quarter 2022 earnings released

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Now 22% undervalued after recent price drop

Second quarter 2022 earnings released

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold €808k worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

Upcoming dividend of kr2.00 per share

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought €552k worth of stock

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Investor sentiment deteriorated over the past week

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold €3.2m worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Independent Chairman recently sold €1.1m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Independent Chairman recently sold €689k worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold €1.4m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share